Trials / Terminated
TerminatedNCT02243696
Protego DF4 Post Approval Registry
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,694 (actual)
- Sponsor
- Biotronik, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this registry study is to confirm the long-term safety and reliability of the Protego DF4 right ventricular lead.
Conditions
Timeline
- Start date
- 2014-09-27
- Primary completion
- 2019-04-17
- Completion
- 2019-04-17
- First posted
- 2014-09-18
- Last updated
- 2020-06-22
- Results posted
- 2020-04-22
Locations
68 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02243696. Inclusion in this directory is not an endorsement.